Advertisement
Advertisement
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
10.56
USDSponsored
+0.26
+2.52%
Nov 10, 15:59 UTC -5
Closed
After-Market
10.55
-0.01
-0.09%
Contineum Therapeutics, Inc. Class A Common Stock (CTNM)
Contineum Therapeutics, Inc. Class A Common Stock Financial Snapshot
| Market Cap | 414.25M |
| Beta | 1.07 |
| Earnings Per Share (EPS) | -1.77 |
| Price-to-Book (P/B) Ratio | 1.50 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -25.48% |
| Current Ratio | 37.17% |
| Free Cash Flow | -28.09M |